グリオブラストーマの治療戦略の進化:伝統的なアプローチと新しい介入

Chirag Shetty¹, Rajesh Tamatta¹, Namdev Dhas²

¹Manipal Centre for Biotherapeutics Research, Manipal Academy of Higher Education, Manipal, India.

3 Biotech

|September 2, 2025

まとめ

グリオブラストーマ (GBM) は,攻撃的な脳腫瘍です. 免疫療法やナノテクノロジーのような新しい治療法は膠芽細胞腫の治療法と患者の生存率を向上させることを示しています

科学分野:

神経腫瘍学
分子生物学
ガン治療薬

背景:

グリオブラストーマ (GBM) は最も攻撃的な原発性脳腫瘍です.
急速な成長,拡散浸透,従来の治療に対する耐性がある.
現在の治療法では生存期間が限られており平均は15~18ヶ月です

研究の目的:

GBMの病理生理学,分子メカニズム,治療の進歩をレビューする.
治療抵抗性を克服し,患者の治療結果を改善するための新興戦略を探求する.
マルチモダルの治療方法の必要性を強調する

主な方法:

グリオブラストームの病理学と治療に関する包括的な文献レビュー.
分子亜型の分析と予後への影響
免疫療法,腫瘍性ウイルス療法,ナノテクノロジーを含む新しい治療戦略の評価.

主要な成果:

GBMは高度に異質で,異なる分子サブタイプがあります.
免疫療法やナノテクノロジーによる薬物投与などの新興治療法では可能性が示されています
免疫抑制性腫瘍の微小環境や血脳障壁を越えた薬の投与など課題が残っています

結論:

新しい治療法と標準的な治療法を統合する多様療法戦略は緊急に必要です
分子プロフィールに基づく個別化医療は膠芽細胞腫の治療の改善に不可欠です
将来の研究は治療抵抗性の克服と薬物投与システムの強化に焦点を当てなければなりません

キーワード:

CAR-T細胞療法がんワクチングリオブラストーマ免疫療法ナノセラピー

さらに関連する動画

12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.5K

08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.3K

関連する概念動画

01:27

Tumor Immunotherapy

659

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

659

02:49

Cancer Therapies

7.9K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

7.9K

02:56

Treatment Resistant Cancers

3.4K

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

3.4K

02:57

Targeted Cancer Therapies

7.8K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...